Skip to content

Features of Regional Perfusion of Lung Consolidation

Evaluation of Regional Perfusion of Lung Consolidation Upon Lung Ultrasonography

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05647967
Enrollment
200
Registered
2022-12-13
Start date
2022-01-01
Completion date
2024-01-31
Last updated
2022-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Injury, Acute, Ultrasound Therapy; Complications

Keywords

lung consolidation, respiratory failure, perfusion

Brief summary

The aim of this study is to evaluate the potential usefulness of lung ultrasound to assess the size and perfusion of consolidation and explore their relationships with clinical outcome.

Detailed description

Lung consolidation is one of the most causes of hypoxia in intensive care unit(ICU) settings. A quantitative measurement of consolidation would be extremely benefit for the clinical management in hypoxemia, both as an index of severity and to predict outcomes.In order to quantify the lung consolidation and its effect on clinical outcomes, a simple and quantitative scoring system of the size and perfusion of lung consolidation was proposed by lung ultrasound. Subjects with respiratory failure and lung consolidation proved by chest imaging underwent lung ultrasound examination. The size of consolidation and the richness of blood flow was computed upon lung ultrasound. The sensitivity, specificity and accuracy of the scoring system were calculated and compared to evaluate the diagnostic efficacy.

Interventions

DIAGNOSTIC_TESTUltrasound

Each patient underwent ultrasound after admission of ICU.

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. Admission to ICU( 18yr\<age\<90yr); 2. Patients presented with acute respiratory failure; 3. Pulmonary consolidation by chest imaging (lung ultrasound, X ray or CT scan).

Exclusion criteria

1. Hemodynamic instability (i.e., severe hypotension with systolic arterial pressure\<60mmHg despite fluid expansion and vasoactive support; systolic arterial pressure\>180mmHg; uncontrolled cardiac arrhythmias); 2. Severe thoracic trauma; 3. Coronavirus disease 2019; 4. Pulmonary artery hypertension and pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
consolidation area indexthrough study completion, an average of 2 yearThe volume of consolidation was measured by consolidation area index (CAI) which is calculated from two-dimensional measures, namely the product of the core distance (from the bottom to the top of the screen) and the longitudinal distance (from the left to the right of the screen).
blood flow scorethrough study completion, an average of 2 yearA semi-quantified scoring system based on the richness of flow signals was established. It identifies four progressive steps of blood signals, each corresponding to a score: no pulsatile blood flow-score 0; sparse dot-like blood flow-score 1; pronounced curvilinear vascularity-score 2; tree-like vascularity-score 3.

Countries

China

Contacts

Primary ContactNa Wang, MD
wangna_pumch2017@163.com17810258960
Backup ContactHuaiwu He, MD
timuhhw@126.com010-69152300

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 5, 2026